Variable | No. of patients | Minimum | Maximum | Median | Mean ± SD |
---|---|---|---|---|---|
Sex | |||||
Female | 2 | ||||
Male | 17 | ||||
Age | 19 | 20 | 61 | 39 | 39.63 ± 11.24 |
Education* | 19 | 2 | 9 | 6 | 5.63 ± 1.98 |
SAPS | 17 | 0 | 50 | 7 | 10.53 ± 13.01 |
SANS | 17 | 0 | 57 | 13 | 17.65 ± 18.21 |
MWT-B | 19 | 21 | 36 | 32 | 30.63 ± 3.65 |
TMT-A | 19 | 19 | 57 | 31 | 32.32 ± 9.67 |
TMT-B | 18 | 38 | 115 | 56 | 62.44 ± 19.68 |
DSST | 19 | 22 | 55 | 45 | 43.63 ± 8.43 |
Chlorpromazine equivalents, mg/d | 18 | 0 | 1390 | 517.36 | 582.96 ± 412.39 |
DSST = Digit Symbol Substitution Test; MWT-B = Multiple-Choice Vocabulary Intelligence Test; SANS = Scale for the Assessment of Negative Symptoms; SAPS = Scale for the Assessment of Positive Symptoms; SD = standard deviation; TMT-A = Trail Making Test A; TMT-B = Trail Making Test B.
↵* As measured by the CASMIN classification.